WTO decision on the TRIPS and Public Health: What does it imply for Bangladesh

Sherajum Monira Farin

No 8, CPD Policy Brief from Centre for Policy Dialogue (CPD)

Abstract: The World Trade Organization (WTO) decision on Trade-related Aspects of Intellectual Property Rights (TRIPS) and Public Health and the derogations provided to the least developed countries (LDCs) did provide a unique business opportunity for Bangladesh. On the other hand, Bangladesh’s graduation from the group of LDCs, by 2024, demands that the country takes adequate measures to prepare for the post-Doha TRIPS regime. This policy brief articulates both the benefits for Bangladesh originating from the WTO decision on TRIPS favouring the LDCs, and the initiatives Bangladesh should undertake to maintain and further consolidate the standing and strength of her pharmaceutical industry.

Keywords: WTO; TRIPS; LDC; Bangladesh; Pharmaceutical Industry; Middle-Income Country; LDC Graduation (search for similar items in EconPapers)
Pages: 4 pages
Date: 2018-05
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://cpd.org.bd/resources/2018/08/Policy-Brief- ... y-for-Bangladesh.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pdb:pbrief:8

Access Statistics for this paper

More papers in CPD Policy Brief from Centre for Policy Dialogue (CPD) Contact information at EDIRC.
Bibliographic data for series maintained by Avra Bhattacharjee ().